Post by mango on May 24, 2022 7:29:11 GMT -5
A Monumental Victory
Validity of the Technosphere Inhalation Technology Platform
Heretofore MannKind was viewed as a struggling biopharma company with one approved product, Afrezza, the inhaled insulin. Today marks a monumental time in the MannKind Story. Today we made history as the first and only FDA approved dry powder inhalation treprostinil therapy for patients with PAH and PH-ILD. This is a glorious victory for patients, MannKind Shareholders, MannKind employees and the legacy of Al Mann.
Tyvaso DPI represents for the second time, a revolutionary, next generation DPI drug device combination product developed and manufactured by MannKind which has been approved by FDA. MannKind has now validated it’s Technosphere technology platform with this monumental FDA approval.
From the banks of despair and uncertainty following the termination of the Sanofi partnership—to a forged alliance with United Therapeutics that has resulted in MannKind’s second FDA approved drug device product utilizing the Technosphere dry powder and inhalation technology platform—this is truly a monumental moment for us all.
Something has changed with MannKind. This is not the same company it once was. We are now a validated, cash equipped, and successful biopharmaceutical company in a position of strength. But what has changed? I believe MannKind’s self efficacy has changed.
Self efficacy is the belief an entity holds regarding their ability to affect a given circumstance or experience. It’s the belief that challenges are experiences that ought to be mastered rather than avoided—a belief that one has the power to affect the future through their choices. A high self efficacy manifests during challenging times—a reoccurring theme we have been witnessing as the MannKind Story unfolds.
It’s with this developed high level of self efficacy that MannKind has managed to be where it is today. MannKind has achieved what few ever will, what few ever could.
Al Mann once said, the three P’s to his success are: Passion, Patience, and Persistence. I believe those attributes are stronger than ever in MannKind today.
Congratulations ya’ll.
Validity of the Technosphere Inhalation Technology Platform
Heretofore MannKind was viewed as a struggling biopharma company with one approved product, Afrezza, the inhaled insulin. Today marks a monumental time in the MannKind Story. Today we made history as the first and only FDA approved dry powder inhalation treprostinil therapy for patients with PAH and PH-ILD. This is a glorious victory for patients, MannKind Shareholders, MannKind employees and the legacy of Al Mann.
Tyvaso DPI represents for the second time, a revolutionary, next generation DPI drug device combination product developed and manufactured by MannKind which has been approved by FDA. MannKind has now validated it’s Technosphere technology platform with this monumental FDA approval.
From the banks of despair and uncertainty following the termination of the Sanofi partnership—to a forged alliance with United Therapeutics that has resulted in MannKind’s second FDA approved drug device product utilizing the Technosphere dry powder and inhalation technology platform—this is truly a monumental moment for us all.
Something has changed with MannKind. This is not the same company it once was. We are now a validated, cash equipped, and successful biopharmaceutical company in a position of strength. But what has changed? I believe MannKind’s self efficacy has changed.
Self efficacy is the belief an entity holds regarding their ability to affect a given circumstance or experience. It’s the belief that challenges are experiences that ought to be mastered rather than avoided—a belief that one has the power to affect the future through their choices. A high self efficacy manifests during challenging times—a reoccurring theme we have been witnessing as the MannKind Story unfolds.
It’s with this developed high level of self efficacy that MannKind has managed to be where it is today. MannKind has achieved what few ever will, what few ever could.
Al Mann once said, the three P’s to his success are: Passion, Patience, and Persistence. I believe those attributes are stronger than ever in MannKind today.
Congratulations ya’ll.